Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Eli Lilly and Co, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Eli Lilly and Co, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Eli Lilly and Co, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Eli Lilly and Co, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Eli Lilly and Co, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Eli Lilly and Co, Medical Equipment, Deal Details 12
Asset Purchase 12
Eli Lilly Acquires Two Alzheimer’s Disease Imaging Agents From Siemens Medical Solutions 12
Venture Financing 14
Veritas Genetics Raises USD30 Million in Series B Financing 14
Millin Enterprises Raises Funds through Series A financing 15
ACEA Biosciences Raises USD30 Million in Venture Financing 16
Microtech Medical Raises Funds through Series A Financing 17
Veritas Genetics Raises USD10 Million in Series A Financing Round 18
Companion Medical Raises USD3.15 Million in Series B Financing 19
Partnerships 20
DexCom Enters into Agreement with Eli Lilly 20
Insulet Enters into Co-Development Agreement with Eli Lilly 21
Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 22
Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 23
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 24
Corgenix Enters Into Co-Development Agreement With Eli Lilly 25
Insulet Enters Into Co-Development Agreement With Eli Lilly 26
Qiagen Enters Into Co-Development Agreement With Eli Lilly 27
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 28
PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 29
Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 30
PETNET Solutions Enters Into Distribution Agreement With Eli Lilly and Company 31
QIAGEN Enters Into Co-Development Agreement With Eli Lilly 32
Synthes Enters Into Co-Development Agreement With Eli Lilly 33
Eli Lilly Enters Into Collaboration With Medtronic 34
Equity Offering 35
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 35
Eli Lilly and Co – Key Competitors 37
Eli Lilly and Co – Key Employees 38
Eli Lilly and Co – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 47
Recent Developments 49
Strategy And Business Planning 49
Sep 07, 2017: Lilly Takes Steps To Streamline Business, Invest In New Medicines And Drive Growth 49
Financial Announcements 50
Oct 24, 2017: Lilly Reports Third-Quarter Results 2017 50
Jul 25, 2017: Lilly Reports Second-Quarter Results 55
Apr 25, 2017: Lilly Reports First-Quarter 2017 Results 59
Jan 31, 2017: Lilly Reports Fourth-Quarter And Full-Year 2016 Results 63
Dec 15, 2016: Lilly Provides 2017 Financial Guidance And 2016 Update, Reaffirms Financial Expectations Through The Remainder Of The Decade 69
Oct 25, 2016: Lilly Reports Third-Quarter 2016 Results 71
Jul 26, 2016: Lilly Reports Second-Quarter 2016 Results, Provides Financial Expectations Through The Remainder Of The Decade 75
Apr 26, 2016: Lilly Reports First-Quarter 2016 Results, Revises 2016 Financial Guidance 79
Jan 28, 2016: Lilly Reports Fourth-Quarter And Full-Year 2015 Results 83
Corporate Communications 89
Dec 11, 2017: Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology 89
Nov 13, 2017: Lilly Appoints Philip Johnson to Senior Vice President and Treasurer 90
Sep 29, 2017: Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing 91
Jun 01, 2017: Derica Rice To Retire As Lilly Chief Financial Officer 92
May 10, 2017: Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications 93
Mar 02, 2017: Lilly Announces Changes In Senior Management 94
Feb 09, 2017: Carolyn R. Bertozzi, Ph.D., Elected To Lilly Board Of Directors 95
Sep 14, 2016: Levi Garraway, M.D., Ph.D., to become Senior Vice President of Global Oncology at Lilly, Succeeding Richard Gaynor, M.D., Who is Retiring after a Distinguished Career 96
Aug 31, 2016: Jamere Jackson Elected To Lilly Board Of Directors 97
Aug 10, 2016: Lilly announces Joshua Smiley, Anat Ashkenazi appointed to new roles, Thomas Grein retires 98
Jul 27, 2016: John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor 99
Jun 13, 2016: Aarti Shah named chief information officer 101
Government and Public Interest 102
Apr 04, 2017: Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students 102
Product News 103
Jul 27, 2016: New Studies Suggest Relationship Between Tau Pathology And Progression Of Alzheimer’s Disease 103
Other Significant Developments 105
Sep 25, 2017: Geisinger And Boehringer Ingelheim Collaborate To Create A Predictive Model To Help Improve Health Outcomes For People With Type 2 Diabetes 105
Jun 21, 2017: Eli Lilly And Company Unveils Expanded Biotechnology Center In San Diego 106
May 17, 2017: Cogstate Selected as Preferred Provider to Lilly’s Alzheimer’s Disease Platform 107
Jan 05, 2017: Lilly To Adjust Organization And Leadership Structure To Better Align With Growth Opportunities 108
Oct 17, 2016: Lilly Partners with the National Cancer Institute to Accelerate Cancer Research through New Program under Cancer Moonshot Initiative 109
Jun 17, 2016: Lilly Launches Domestic Production of Entire Range of Humulin, Humalog Insulins and Long Acting Insulin Analogue in partnership with R-Pharm Group 110
May 24, 2016: Lilly Details Robust R&D Pipeline to Investment Community 111
Feb 24, 2016: Indiana Biosciences Research Institute Announces $100 Million in Grants Supporting Scientific Innovation to Address Metabolic Disease and Poor Nutrition 112
Appendix 113
Methodology 113
About GlobalData 113
Contact Us 113
Disclaimer 113
Eli Lilly and Co, Medical Equipment, Key Facts, 2016 2
Eli Lilly and Co, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Eli Lilly and Co, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Eli Lilly and Co, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Eli Lilly and Co, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Eli Lilly and Co, Deals By Market, 2011 to YTD 2017 9
Eli Lilly and Co, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions 12
Veritas Genetics Raises USD30 Million in Series B Financing 14
Millin Enterprises Raises Funds through Series A financing 15
ACEA Biosciences Raises USD30 Million in Venture Financing 16
Microtech Medical Raises Funds through Series A Financing 17
Veritas Genetics Raises USD10 Million in Series A Financing Round 18
Companion Medical Raises USD3.15 Million in Series B Financing 19
DexCom Enters into Agreement with Eli Lilly 20
Insulet Enters into Co-Development Agreement with Eli Lilly 21
Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 22
Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 23
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 24
Corgenix Enters Into Co-Development Agreement With Eli Lilly 25
Insulet Enters Into Co-Development Agreement With Eli Lilly 26
Qiagen Enters Into Co-Development Agreement With Eli Lilly 27
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 28
PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 29
Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 30
PETNET Solutions Enters Into Distribution Agreement With Eli Lilly and Company 31
QIAGEN Enters Into Co-Development Agreement With Eli Lilly 32
Synthes Enters Into Co-Development Agreement With Eli Lilly 33
Eli Lilly Enters Into Collaboration With Medtronic 34
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 35
Eli Lilly and Co, Key Competitors 37
Eli Lilly and Co, Key Employees 38
Eli Lilly and Co, Subsidiaries 40
Eli Lilly and Co, Joint Venture 47